Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Selects GenoLogics' LIMS Software to Support HiSeq Customers

NEW YORK (GenomeWeb) – GenoLogics said today that Illumina has selected its Clarity laboratory information management system (LIMS) as the preferred software for customers of its HiSeq X Ten sequencing platform.

With this announcement, GenoLogics makes good on a promise it made earlier this year that an upcoming release of Clarity would include support for the HiSeq X Ten. Together, the companies are currently working on support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those that will be used inside of Illumina, GenoLogics said. Additionally, Illumina will use Clarity to support its collaboration with Genomics England to sequence 100,000 genomes.

"Illumina is pleased to be working with GenoLogics to ensure HiSeq X Ten customers receive the LIMS support they need," Alex Dickinson, Illumina's senior vice president of strategic initiatives, said in a statement. "Scaling a lab to deliver the $1,000 genome presents unique challenges and GenoLogics has the demonstrated ability and understanding of our technologies to support these labs."

GenoLogics' Clarity already supports Illumina's TruSight individual genome sequencing test as well as its HiSeq, MiSeq, and Genome Analyzer sequencers.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.